• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁酸盐通过增强肠道屏障功能和 FFA2 介导的 PI3K/Akt/mTOR 信号改善糖尿病肾病骨骼肌萎缩。

Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K/Akt/mTOR signals.

机构信息

Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Br J Pharmacol. 2022 Jan;179(1):159-178. doi: 10.1111/bph.15693. Epub 2021 Nov 23.

DOI:10.1111/bph.15693
PMID:34638162
Abstract

BACKGROUND AND PURPOSE

Muscle protein catabolism in patients with diabetic nephropathy (DN) results in striking loss of muscle proteins, which increases morbidity and mortality risks. Evidence shows that short-chain fatty acids (SCFAs) play an important role in health maintenance and disease development. Recently, the connection between butyrate (a SCFA) and DN has been revealed, although the relationship between butyrate and muscle atrophy remains unclear.

EXPERIMENTAL APPROACH

We studied changes in serum butyrate levels in DN patients using metabolomic analyses. In db/db mice, protective effects of butyrate on DN-induced muscle atrophy. were explored. Inhibition of muscle atrophy by butyrate and the underlying mechanism(s) were studied in C2C12 cells exposed to high glucose/lipopolysaccharide (HG/LPS).

KEY RESULTS

Butyrate levels in DN patients were significantly decreased. In db/db mice, supplementing normal diet with butyrate improved intestinal barrier function. Concurrently, butyrate alleviated muscle atrophy, promoted PI3K/Akt/mTOR signalling, and suppressed oxidative stress and autophagy in skeletal muscle of db/db mice, and in HG/LPS-exposed C2C12 cells. Further, FFA2 receptors, key components of SCFA signalling, were decreased in skeletal muscle of db/db mice and in HG/LPS-exposed C2C12 cells. Overexpression of FFA2 receptors activated PI3K/Akt/mTOR signalling and inhibited oxidative stress and autophagy in HG/LPS-exposed C2C12 cells. Silencing of FFA2 blocked PI3K/Akt/mTOR signalling that was improved by butyrate, as well as the suppression of oxidative stress and reduction of autophagy.

CONCLUSION AND IMPLICATION

Butyrate exerts protective effects on muscle atrophy induced by DN by enhancing intestinal barrier function and activating the FFA2 receptor-mediated PI3K/Akt/mTOR pathway.

摘要

背景与目的

糖尿病肾病(DN)患者的肌肉蛋白分解导致肌肉蛋白大量丢失,增加了发病率和死亡率风险。有证据表明,短链脂肪酸(SCFAs)在维持健康和疾病发展中起着重要作用。最近,丁酸(一种 SCFA)与 DN 之间的联系已经被揭示,尽管丁酸与肌肉萎缩之间的关系尚不清楚。

实验方法

我们使用代谢组学分析研究了 DN 患者血清丁酸水平的变化。在 db/db 小鼠中,研究了丁酸对 DN 诱导的肌肉萎缩的保护作用。在高糖/脂多糖(HG/LPS)暴露的 C2C12 细胞中,研究了丁酸对肌肉萎缩的抑制作用及其潜在机制。

主要结果

DN 患者的丁酸水平显著降低。在 db/db 小鼠中,在正常饮食中补充丁酸可改善肠道屏障功能。同时,丁酸缓解了 db/db 小鼠骨骼肌的萎缩,促进了 PI3K/Akt/mTOR 信号通路,并抑制了骨骼肌的氧化应激和自噬,以及 HG/LPS 暴露的 C2C12 细胞。此外,FFA2 受体,SCFA 信号的关键组成部分,在 db/db 小鼠和 HG/LPS 暴露的 C2C12 细胞中的骨骼肌中减少。FFA2 受体的过表达激活了 PI3K/Akt/mTOR 信号通路,并抑制了 HG/LPS 暴露的 C2C12 细胞中的氧化应激和自噬。FFA2 沉默阻断了丁酸改善的 PI3K/Akt/mTOR 信号通路,以及氧化应激的抑制和自噬的减少。

结论和意义

丁酸通过增强肠道屏障功能和激活 FFA2 受体介导的 PI3K/Akt/mTOR 通路,对 DN 诱导的肌肉萎缩发挥保护作用。

相似文献

1
Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K/Akt/mTOR signals.丁酸盐通过增强肠道屏障功能和 FFA2 介导的 PI3K/Akt/mTOR 信号改善糖尿病肾病骨骼肌萎缩。
Br J Pharmacol. 2022 Jan;179(1):159-178. doi: 10.1111/bph.15693. Epub 2021 Nov 23.
2
The metabolite butyrate produced by gut microbiota inhibits cachexia-associated skeletal muscle atrophy by regulating intestinal barrier function and macrophage polarization.肠道微生物产生的代谢产物丁酸盐通过调节肠道屏障功能和巨噬细胞极化抑制恶病质相关的骨骼肌萎缩。
Int Immunopharmacol. 2023 Nov;124(Pt B):111001. doi: 10.1016/j.intimp.2023.111001. Epub 2023 Oct 5.
3
Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K/AKT/mTOR pathway in diabetic kidney disease.芦丁通过抑制 PI3K/AKT/mTOR 通路中的 HDAC1 来恢复自噬,从而减轻糖尿病肾病中的 EndMT。
Phytomedicine. 2023 Apr;112:154700. doi: 10.1016/j.phymed.2023.154700. Epub 2023 Feb 4.
4
mixture attenuates renal damage in rats with diabetic nephropathy by inhibiting the PI3K/Akt/mTOR pathway.该混合物通过抑制 PI3K/Akt/mTOR 通路来减轻糖尿病肾病大鼠的肾脏损伤。
Mol Med Rep. 2021 Aug;24(2). doi: 10.3892/mmr.2021.12229. Epub 2021 Jun 24.
5
Renoprotective Effect of Isoorientin in Diabetic Nephropathy via Activating Autophagy and Inhibiting the PI3K-AKT-TSC2-mTOR Pathway.异荭草苷通过激活自噬和抑制 PI3K-AKT-TSC2-mTOR 通路对糖尿病肾病的肾保护作用。
Am J Chin Med. 2023;51(5):1269-1291. doi: 10.1142/S0192415X23500581. Epub 2023 Jun 17.
6
Irisin ameliorates diabetic kidney disease by restoring autophagy in podocytes.鸢尾素通过恢复足细胞的自噬来改善糖尿病肾病。
FASEB J. 2023 Oct;37(10):e23175. doi: 10.1096/fj.202300420R.
7
[Down-regulation of PHLPP1 expression ameliorates high glucose-induced autophagy inhibition and apoptosis promotion of podocytes by activating PI3K/AKT/mTOR pathway].[PHLPP1表达下调通过激活PI3K/AKT/mTOR通路改善高糖诱导的足细胞自噬抑制和凋亡促进作用]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2021 Jan;37(1):8-15.
8
Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury.糖尿病肾病中肠道微生物群的变化及其对肾损伤进展的影响。
Endocrine. 2022 May;76(2):294-303. doi: 10.1007/s12020-022-03002-1. Epub 2022 Mar 4.
9
Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress.螺内酯通过抑制PI3K/AKT/mTOR信号通路促进自噬,并减轻机械应激下足细胞的黏附能力损伤。
Biosci Rep. 2016 Jul 7;36(4). doi: 10.1042/BSR20160086. Print 2016 Aug.
10
LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway.长链非编码RNA Hoxb3os通过依赖Akt-mTOR信号通路的自噬保护足细胞免受高糖诱导的细胞损伤。
Acta Biochim Pol. 2021 Oct 14;68(4):619-625. doi: 10.18388/abp.2020_5483.

引用本文的文献

1
Gut Microbiome-Derived Short-Chain Fatty Acids in Glomerular Protection and Modulation of Chronic Kidney Disease Progression.肠道微生物群衍生的短链脂肪酸在肾小球保护及慢性肾脏病进展调控中的作用
Nutrients. 2025 Sep 8;17(17):2904. doi: 10.3390/nu17172904.
2
Alleviates Sarcopenia in Senescence-Accelerated Mouse-Prone 8 Mice.缓解衰老加速易患8型小鼠的肌肉减少症。
J Microbiol Biotechnol. 2025 Aug 26;35:e2507001. doi: 10.4014/jmb.2507.07001.
3
Differential Impacts of Environmentally Relevant Microplastics on Gut Barrier Integrity in Mice Fed High-Fat Diet Versus Normal Chow Diet.
环境相关微塑料对高脂饮食小鼠与正常饮食小鼠肠道屏障完整性的不同影响
Metabolites. 2025 Aug 20;15(8):557. doi: 10.3390/metabo15080557.
4
Curcumin/piperine modulates the butyrate levels and alleviates diabetic kidney disease via Nrf2/HO-1 signaling pathway.姜黄素/胡椒碱通过Nrf2/HO-1信号通路调节丁酸盐水平并减轻糖尿病肾病。
Ren Fail. 2025 Dec;47(1):2538117. doi: 10.1080/0886022X.2025.2538117. Epub 2025 Aug 7.
5
Systemic and Retinal Protective Effects of Butyrate in Early Type 2 Diabetes via Gut Microbiota-Lipid Metabolism Interaction.丁酸通过肠道菌群-脂质代谢相互作用对早期2型糖尿病的全身及视网膜保护作用
Nutrients. 2025 Jul 18;17(14):2363. doi: 10.3390/nu17142363.
6
Role of Gut Microbiota and Metabolite Remodeling on the Development and Management of Rheumatoid Arthritis: A Narrative Review.肠道微生物群和代谢物重塑在类风湿性关节炎发展与管理中的作用:一项叙述性综述
Vet Sci. 2025 Jul 5;12(7):642. doi: 10.3390/vetsci12070642.
7
Immune inflammation and metabolic interactions in the pathogenesis of diabetic nephropathy.糖尿病肾病发病机制中的免疫炎症与代谢相互作用
Front Endocrinol (Lausanne). 2025 Jul 8;16:1602594. doi: 10.3389/fendo.2025.1602594. eCollection 2025.
8
Gut microbiota-derived SCFAs and MetS-related nephropathy.肠道微生物群衍生的短链脂肪酸与代谢综合征相关肾病
Front Nutr. 2025 Jul 8;12:1561271. doi: 10.3389/fnut.2025.1561271. eCollection 2025.
9
TGFβ1 accelerated the progression of diabetic nephropathy via up-regulating BRD4/Notch1/YAP signaling induced fibrosis and proliferation in fibroblasts.转化生长因子β1通过上调BRD4/Notch1/YAP信号通路诱导成纤维细胞纤维化和增殖,从而加速糖尿病肾病的进展。
Sci Rep. 2025 Jul 13;15(1):25338. doi: 10.1038/s41598-025-10143-6.
10
Melatonin Mitigates Sarcopenic Obesity via Microbiota and Short-Chain Fatty Acids: Evidence From Epidemiologic and In Vivo Studies.褪黑素通过微生物群和短链脂肪酸减轻肌肉减少性肥胖:来自流行病学和体内研究的证据。
J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13869. doi: 10.1002/jcsm.13869.